Saturday, September 5, 2015

Deals

Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine

September 2, 2015 · Leave a Comment 

  WILMINGTON, Del.–Incyte Corporation (Nasdaq: INCY) today announced a global license and collaboration agreement with Jiangsu Hengrui Medicine Co., Ltd. for the development and commercialization of SHR-1210, an investigational anti-PD-1 monoclonal antibody. Under the agreement, Incyte will have the exclusive development and commercialization rights to SHR-1210 worldwide, with the exception of Mainland China, Hong Kong, Macau, and Taiwan. SHR-1210 is expected to enter proof-of-concept studies for the treatment of patients with advanced solid tumors in the coming months.  Read More →

Deal News

Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine

September 2, 2015 · Leave a Comment 

  WILMINGTON, Del.–Incyte Corporation (Nasdaq: INCY) today announced a global license and collaboration agreement with Jiangsu Hengrui Medicine Co., Ltd. for the development and commercialization of SHR-1210, an investigational anti-PD-1 monoclonal antibody. Under the agreement, Incyte will have the exclusive development and commercialization rights to SHR-1210 worldwide, with the exception of Mainland China, Hong Kong, Macau, and Taiwan. SHR-1210 is expected to enter proof-of-concept studies for the treatment of patients with advanced solid tumors in the coming months.  Read More →

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine

September 2, 2015 · Leave a Comment 

  WILMINGTON, Del.–Incyte Corporation (Nasdaq: INCY) today announced a global license and collaboration agreement with Jiangsu Hengrui Medicine Co., Ltd. for the development and commercialization of SHR-1210, an investigational anti-PD-1 monoclonal antibody. Under the agreement, Incyte will have the exclusive development and commercialization rights to SHR-1210 worldwide, with the exception of Mainland China, Hong Kong, Macau, and Taiwan. SHR-1210 is expected to enter proof-of-concept studies for the treatment of patients with advanced solid tumors in the coming months.  Read More →

University Tech Transfer

Allied-Bristol Life Sciences Licenses from Yale University

August 27, 2015 · Leave a Comment 

  BOSTON–Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned between Allied Minds (LSE: ALM) and Bristol-Myers Squibb Company (NYSE: BMY), announced that it has entered into a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules that will be further developed to treat diseases such as prostate cancer, a leading cause of cancer-related deaths among American men. Developed by Professor David A. Spiegel, Ph.D., M.D. and his team at Yale University, the proprietary synthetic molecules, known as... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine

  WILMINGTON, Del.–Incyte Corporation (Nasdaq: INCY) today announced a global license and collaboration agreement with Jiangsu Hengrui Medicine Co., Ltd. for the development and commercialization of SHR-1210, an investigational anti-PD-1 monoclonal antibody. Under the agreement, Incyte will have the exclusive development and commercialization... Read more of this article


AstraZeneca (AZN) Enters Commercialization Agreement with Daiichi Sankyo

  AstraZeneca (NYSE: AZN) announced that its global biologics research and development arm, MedImmune, has entered an agreement granting Daiichi Sankyo Company, Ltd. (Daiichi Sankyo) an exclusive license to develop and commercialise FluMist Quadrivalent in Japan. FluMist Quadrivalent is a live attenuated influenza vaccine which is administered... Read more of this article


WiLAN Subsidiary Enters into License Agreement with Lexmark

  OTTAWA, CANADA, Sep 02, 2015 WiLAN (WIN) WILN, -3.03% today announced that the Company’s subsidiary, Open Network Systems Inc., has entered into a patent license agreement with Lexmark International Inc. The licensed patents relate to networking capabilities of non-standard devices. The licensed technologies enable devices, including point... Read more of this article


Theratechnologies Announces Commercialization Agreement

  MONTREAL, CANADA, Aug 31, 2015 — Theratechnologies Inc. (TH) is pleased to announce that it has concluded an agreement with BL&H Co., LTD (BL&H) for the distribution and commercialization of EGRIFTA(TM) (tesamorelin for injection) for the treatment of HIV-associated lipodystrophy in South Korea. Under the terms of this agreement,... Read more of this article


Neonode Signs Multi-Year License Agreement With Leading Japanese Printer OEM

  Neonode Inc. NEON, -1.37% the leading optical touch and proximity technology company has signed a multi-year, multi-device license agreement with a leading Japanese printer OEM. The signing of the license agreement comes as follow-on from the development agreement which was the first step in the process of technology validation by this printer... Read more of this article


Naturally Splendid Enters into Restated License Agreement with Full Spectrum Laboratories

  BURNABY, BRITISH COLUMBIA September 1, 2015 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or the “Company”) (TSX VENTURE: NSP) (OTCQB: NSPDF) (FRANKFURT: 50N) is pleased to announce that it has now procured outright ownership of all the omega technologies from Full Spectrum Laboratories (FSL) including... Read more of this article


Celyad Announces Commercial License Agreement in Greater China

  MONT-SAINT-GUIBERT, Belgium, Aug. 31, 2015 — Celyad SA(Euronext Brussels, Euronext Paris and Nasdaq:CYAD), a leader in the discovery and development of engineered cell therapies, today announced that it has entered into a new collaboration and distribution agreement with its Hong-Kong based partner, Medisun International Limited (“Medisun”).... Read more of this article


Neoconix, Samtec Renew Technology License Agreement

  SAN JOSE, Calif., Aug. 31, 2015 — Neoconix, Inc. is pleased to announce that Samtec, Inc. has renewed their Neoconix PCBeam™ technology license agreement to continue their dual source arrangement on the Samtec Z-Ray® product line. This dual source arrangement allows Samtec to support new customers with an additional variety of fine... Read more of this article


Albany Molecular Research, Saneca Pharma Enter API-Focused Strategic Collaboration

  Albany Molecular Research (NASDAQ: AMRI) and Saneca Pharmaceuticals, a.s. announced a strategic collaboration focused on the development, manufacture and marketing of a portfolio of opium-derived active pharmaceutical ingredients, (“APIs”). The collaboration combines Saneca’s strength in extracting opiates from plant biomass... Read more of this article


Therapeutic Solutions International Acquires From OmniBiome Therapeutics Inc.

  Therapeutics Solutions International (OTC PINK: TSOI) announced today the signing of an intellectual property purchase agreement with OmniBiome Therapeutics Inc., in which proprietary know-how related to modulating the immune system using commercially-available probiotics to prevent complications of pregnancy including pre-term labor and immunologically-mediated... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

Allied-Bristol Life Sciences Licenses from Yale University

  BOSTON–Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise... 


Tekcapital Buys Nine Air Conditioning Patents

  LONDON – Technology and intellectual property services company Tekcapital... 


More Posts From University Tech Transfer